Technological Innovation in Health Care and the Long-Term Fiscal Outlook
Technological Innovation in Health Care and the Long-Term Fiscal Outlook
批准号:
8750769
负责人:
DANA P GOLDMAN
金额:
$39.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-15 至 2016-06-30
关键词:
AccountingAgeAgingAmericanBehavioralBehavioral ModelBudgetsCaringComplementDiseaseEconomic ModelsEconomicsElderlyEquilibriumEvolutionFeedbackFutureGenerationsGovernmentGrowthHealthHealth Care CostsHealth PolicyHealthcareHeartIncomeInsuranceKnowledgeLabor ForcesLifeLiteratureLongevityMapsMedicalMedical TechnologyMedicareMedicare/MedicaidModelingOutcomePast TrendsPharmacologic SubstancePoliciesPopulationPopulation GrowthPriceProductionResearchRoleRunningScientific Advances and AccomplishmentsSocial ValuesSocial WelfareStreamTechnologyTimeUnited StatesUnited States Centers for Medicare and Medicaid Servicesagedaging populationbasecosteconomic outcomefallsfunctional statusinnovationmodels and simulationmortalitypopulation healthprogramspublic health relevancesimulationtechnological innovationtrend
中文摘要
描述(由申请人提供):在过去的50年里,人类的寿命稳步增长。老年人的功能状况也有了重要的改善,尽管最近已经趋于平稳。这些改进并非没有成本。在同一时期,美国将其收入中越来越大的份额用于医疗保健。部分由于预计医疗费用将增加,美国的长期财政前景面临重大挑战。国会预算办公室和医疗保险和医疗补助服务中心(CMS)的财政预测非常糟糕,医疗保险支出占国民收入的比例预计将增加一倍以上,从今天的3.7%增加到2050年的7.3%。然而,这些预测将医疗保健成本的驱动因素——技术——视为外生因素或固定因素。这是不现实的。我们知道创新者会最大化未来利润流的预期价值,他们会考虑未来对其创新的需求。拟议的研究将结合来自卫生政策和宏观经济领域的两种不同但互补的方法。首先,我们将把技术变革及其决定因素纳入预测美国长期财政前景的现有模型中。我们的引擎将是一个涵盖25岁及以上人口的经济人口微观模拟,即未来美国人模型(FAM)。这一方法将检查细微的技术变革,以了解支出和人口健康的后果。其次,我们将建立一个宏观经济增长模型,以了解重叠代(OLG)的内生创新和医疗保健支出,该模型结合了我们的经济人口模拟预测。事实证明,这种OLG模型对于理解长期经济结果及其对政府债务的影响非常有用。OLG模型的结果将通过揭示在考虑行为和宏观经济变化时与平衡政府预算一致的财政路径来补充FAM的结果。这个项目有四个主要成果。首先,我们将量化各种创新情景的财政后果。其次,研究将确定新的创新将通过有效治疗一种疾病同时影响其他疾病的创新来影响健康的情景。第三,该项目将确定未来几年卫生支出因技术变革而上升或下降的情景,以及如何利用粮农组织校准的OLG模型在对福利影响最小的情况下为卫生支出提供资金。第四,通过将行为模型与模拟模型(如未来美国人模型)相结合,该项目将提高人们对结合不同方法进行长期财政预测的可能性的认识。
英文摘要
DESCRIPTION (provided by applicant): Over the past 50 years, longevity has risen at a steady pace. Functional status of the elderly has also witnessed important improvements, although gains have leveled off recently. These improvements do not come without costs. The United States has devoted an increasing share of its income to health care over that same period. In part because of the projected increase of health costs, the long-term fiscal outlook of the U.S. presents important challenges. Fiscal forecasts from the Congressional Budget Office and the Centers for Medicare & Medicaid Services (CMS) are dire, with Medicare spending alone projected to more than double as a share of national income, from 3.7% today to 7.3% in 2050. However, these forecasts take the driver of health care costs-technology-as exogenous, or fixed. This is unrealistic. We know innovators maximize the expected value of a future profit stream, and they will take into account the demand for their innovations in the future. The proposed research will marry two distinct but complementary approaches from the health policy and macroeconomic fields. First, we will incorporate technological change, and its determinants, into existing models projecting the long- term fiscal outlook of the U.S. Our engine will be an economic-demographic microsimulation that covers the population aged 25 and older, the Future Americans Model (FAM). This approach will examine granular technological change to understand consequences for spending and population health. Second, we will build a macroeconomic growth model to understand endogenous innovation and health care spending in overlapping generations (OLG) that incorporates the projections of our economic-demographic simulation. Such OLG models have proven very useful for understanding long-run economic outcomes and their effects on government debt. Results from the OLG model will complement the results of the FAM by revealing the fiscal paths consistent with a balanced government budget when taking behavioral and macroeconomic changes into account. There are four principal outcomes of this project. First, we will quantify the fiscal consequences of various innovation scenarios. Second, the research will identify scenarios under which new innovations will impact health by effectively treating one disease while simultaneously impacting innovation for other diseases. Third, the project will identify scenarios under which health spending would rise or fall in future years as a result of technological change and how health spending can be financed with minimum welfare consequences using the FAM-calibrated OLG model. Fourth, by combining behavioral models with simulation models such as the Future Americans Model, this project will advance the state of knowledge on the possibilities of combining different approaches to make long-term fiscal forecasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10216946
-
项目类别:
-
资助金额:$8.55万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10417203
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
-
批准号:10657377
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2020
-
负责人:DANA P GOLDMAN
-
依托单位:
Precision Medicine: Moving Theory into Practice
-
批准号:9752826
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2019
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:9977782
-
项目类别:
-
资助金额:$54.69万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:10176332
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
-
批准号:9789172
-
项目类别:
-
资助金额:$61.65万
-
财政年份:2018
-
负责人:DANA P GOLDMAN
-
依托单位:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
-
批准号:9176837
-
项目类别:
-
资助金额:$69.01万
-
财政年份:2016
-
负责人:DANA P GOLDMAN
-
依托单位:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
-
批准号:9321379
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2016
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8987153
-
项目类别:
-
资助金额:$8.44万
-
财政年份:2015
-
负责人:DANA P GOLDMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8395435
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8535592
-
项目类别:
-
资助金额:$51.34万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8374285
-
项目类别:
-
资助金额:$57.21万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8688127
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
The Science of Alzheimer's Disease and Related Dementias
-
批准号:9927447
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
RCMAR - Administrative Core
-
批准号:10451545
-
项目类别:
-
资助金额:$18.99万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:9982152
-
项目类别:
-
资助金额:$54.43万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
COMMUNITY LIAISON CORE
-
批准号:8395437
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
USC Resource Center for Minority Aging Research (US-RCMAR)
-
批准号:8896384
-
项目类别:
-
资助金额:$51.3万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
RCMAR - Administrative Core
-
批准号:10218034
-
项目类别:
-
资助金额:$18.99万
-
财政年份:2012
-
负责人:DANA P GOLDMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: